文献速递毛发、甲与色素性疾病

VALIANT全球研究:白癜风自然史与治疗历程的患者及医护人员认知

Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study.
PubMed 文献 · Br J Dermatol · 2023-01-01

VALIANT研究是首个全球性调查,通过在线面板在17个国家招募3541例成人白癜风患者和1203名医护人员,探讨白癜风自然史与管理。患者平均2.4年后获正式诊断,44.9%报告曾被误诊,56.7%被告知白癜风无法治疗;26.3%医护人员认为无有效疗法,44.6%患者放弃寻找有效治疗。患者与医护人员的首要治疗目标相似。

要点

  • 45.2%患者皮损面积超过5%体表面积,57.1%报告家族史。
  • 患者平均2.4年后获正式诊断,44.9%报告曾被误诊。
  • 56.7%患者被告知白癜风无法治疗,44.6%患者放弃寻找有效疗法。

核心结论

  • 患者与医护人员报告相似的治疗目标,并对缺乏有效疗法表示沮丧。
  • 患者报告初始误诊率高;许多患者因认为白癜风无法治疗而停止寻求医疗。
  • 研究结果强调需要更早诊断和改善白癜风疾病管理。

研究设计与样本

  • VALIANT研究是首个从患者和医护人员角度探讨白癜风自然史与管理的全球性调查。
  • 通过在线面板在17个国家招募≥18岁确诊白癜风成人患者和诊治白癜风的医护人员。
  • 分析纳入3541例患者和1203名医护人员。

主要发现

  • 45.2%患者皮损面积超过5%体表面积;57.1%报告家族史。
  • 患者平均(SD)2.4(4.1)年后获得正式诊断;44.9%报告曾被误诊。
  • 56.7%患者报告被告知白癜风无法治疗;53.9%医护人员认为从未治疗的白癜风患者曾被告知白癜风无法治疗。
  • 26.3%医护人员不相信存在有效白癜风疗法;44.6%患者报告放弃寻找有效疗法。
  • 患者和医护人员首要治疗目标分别为减少或停止扩散(24.7%和18.5%)和复色(22.5%和37.2%)。

关键数值与推荐

  • 患者对有效治疗的感知:皮肤科医生治疗为66.9%,基层医疗医护人员治疗为67.0%。

临床怎么用

  • 研究结果提示需要更早诊断和改善白癜风疾病管理。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vitiligo is a chronic autoimmune disease affecting melanocytes, resulting in skin depigmentation. Patients with vitiligo often have reduced quality of life and comorbid autoimmune conditions and have reported a lack of available treatments for their vitiligo. OBJECTIVES: The Vitiligo and Life Impact Among International Communities (VALIANT) study is the first global survey to explore the natural history and management of vitiligo from the perspectives of patients and healthcare professionals (HCPs). METHODS: The survey recruited adults (≥ 18 years) diagnosed with vitiligo and HCPs treating patients with vitiligo via an online panel in 17 countries. Patients were queried regarding clinical characteristics and vitiligo treatment. HCPs were queried regarding diagnosis and management of patients with vitiligo. RESULTS: Included in the analysis were 3541 patients and 1203 HCPs. Nearly half (45.2%) of the patients had > 5% affected body surface area; 57.1% reported family history. Patients obtained formal diagnosis after a mean (SD) of 2.4 (4.1) years; 44.9% reported previous misdiagnosis. Many patients (56.7%) reported being told that vitiligo could not be treated; 53.9% of HCPs believed patients who never treated their vitiligo had been told that vitiligo could not be treated. One-quarter of HCPs (26.3%) did not believe that an effective therapy for vitiligo exists; 44.6% of patients reported giving up on finding an effective therapy. Top treatment goals for patients and HCPs, respectively, were reduction or cessation of spread (24.7% and 18.5%) and repigmentation (22.5% and 37.2%). Patient perception of effective care was similar for treatment by dermatologists (66.9%) and primary care HCPs (67.0%). CONCLUSIONS: Patients with vitiligo and HCPs reported similar treatment goals and expressed frustration with the lack of effective therapies. Patients reported high rates of initial misdiagnosis; many ceased seeking healthcare because they perceived that vitiligo could not be treated. The findings highlight the need for earlier diagnosis and improved disease management for vitiligo.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Hamzavi IH, Bibeau K, Grimes P, et al. Exploring the natural and treatment history of vitiligo: perceptions of patients and healthcare professionals from the global VALIANT study. Br J Dermatol. 2023. PMID: 37493275. doi:10.1093/bjd/ljad245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。